May 11, 2022 | By John Raslavsky | Clinical Research, Hepatitis C | Blog, Clinical trials, Liver research, NASH
Hepatitis C is a liver infection from the hepatitis C virus (HCV). For some people, HCV causes short-term illness. However, for more than half, it becomes a long-term, chronic infection that can result in severe and life-threatening health problems. Liver …
April 26, 2022 | By John Raslavsky | Clinical Research, Effects of Alcohol on the Liver, Fibroscan | AFLD, Blog, Clinical trials, Fatty Liver Disease, liver health
Alcohol is one of the most widely used substances among America’s adult and teen populations, posing substantial health and safety risks. Even though most know the adverse effects of alcohol, many tend to do so without fully recognizing the health …
April 7, 2022 | By John Raslavsky | Clinical Trials, Liver Disease, Minority Participation in Liver Research | Blog, Diversity in research, Fatty Liver Disease, NAFLD, NASH, National Minority Health Month
April is National Minority Health Month (NMHM), a time to raise awareness about health disparities that affect people from racial and ethnic minority groups. Liver disease is growing in prevalence in the Hispanic population. It is also a leading cause …
March 30, 2022 | By John Raslavsky | Clinical Research, Hepatitis | Blog, Clinical trials, Fatty Liver Disease, liver health, Liver research, NAFLD, NASH
Liver health is essential to the function of the human body. It performs over 500 functions to keep the body healthy. A few examples are flushing out toxins, processing food, and maintaining healthy blood sugar levels. Hepatitis is one of …
March 7, 2022 | By John Raslavsky | Fibroscan, Liver Disease | Blog, NAFLD, NASH, Women's History Month
March is Women’s History Month, and it commemorates women’s contributions to history, culture, and society. The 2022 theme is “Women Providing Healing, Promoting Hope.” It is a tribute to the countless ways women of all cultures provide healing and hope …
February 28, 2022 | By John Raslavsky | Clinical Trials, Liver Health | Blog, liver disease research, NAFLD, NASH
There’s a lot of love to celebrate during the month of February. However, some of the things we love are bad for our overall health. One of these areas is our obsession with the “western diet,” which is high in …
February 14, 2022 | By John Raslavsky | Clinical Research, Liver Health | American heart month, Blog, Clinical trials, heart-liver connection, Liver research
When we think of hearts, we think of Valentine’s Day and the exchange of cards and unique trinkets shared with our family and friends. February is also American Heart Month which creates awareness about heart disease, the number one cause …
January 31, 2022 | By John Raslavsky | Clinical Trials, Liver | Blog, liver health, Liver research, NAFLD, NASH
You can start this year on the right foot by taking proactive steps for your health and well-being. If you’ve been diagnosed with liver disease, keeping your liver healthy is essential. It’s a new year, and it’s time to set …
December 14, 2021 | By John Raslavsky | Clinical Research, PCOS | Blog, Hepatic Clinical Trials, liver health, NAFLD, NASH
The prevalence of non-alcoholic fatty liver disease (NAFLD), a condition that encompasses excess fat accumulation, inflammation, and liver scarring, is on the rise. Multiple factors go into developing NAFLD, and it has been linked to several other conditions. Polycystic ovary …
November 29, 2021 | By John Raslavsky | Clinical Research, NAFLD | Blog, Clinical trials, Fatty Liver Disease, liver health
In the medical world, we are always trying to find new ways to treat all kinds of conditions. Non-alcoholic fatty liver disease, or NAFLD, is a condition that we are constantly learning more about, especially in the work of clinical …